Risultati per 'Abcam':
Di seguito l'elenco dei risultati di ricerca trovati rilevanti per la keyword 'Abcam':
Risultati maggiormente rilevanti:
abcam - antibodies, proteins, kits and reagents for life ...
Abcam, the leading supplier of protein research tools to life scientists. Discover more from a range of 118,000 antibodies, kits, proteins and other reagents
primary antibodies | abcamAbcam’s primary antibodies are validated in multiple applications and species with supporting data on every datasheet.
home - abcamAbcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.
Altri risultati:
ricerca scientifica | abcamAbcam nasce nel 1998 nel Regno Unito con l’obiettivo di diventare un fornitore di anticorpi e reagenti di alta qualità, offrendo un ventaglio di prodotti costantemente aggiornato. I settori su cui si focalizza l’offerta di Abcam sono quelli della Ricerca sul Cancro, Cardiovascolare, Chromatin e Nuclear Signaling, Immunologia, Neuroscienze e Cellule Staminali.
about careers at abcamIt’s our goal to provide a world-standard in protein research tools, technical support and delivery. When you join Abcam, you’ll join a global business with the passion and the vision to become the most influential company and best-loved brand in life sciences. Our culture is our key differentiator.
about us - abcamAbcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research.
abcam - wikipediaAbcam also has a portfolio of non-antibody related products such as biochemicals, cellular assays, and epigenetics kits (e.g. FirePlex Multiplex miRNA Kits). Abcam is listed on the London Stock Exchange. Acquisitions. In May 2011, Abcam announced the acquisition of MitoSciences, a privately held biotech company based in Eugene, Oregon (US).